Psychiatry & Neurology Doctors in N Miami Beach, FL Accepting Medicare

2 Psychiatry & Neurology doctors found. Showing 1 - 2

Dr. Larry Benovitz, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1550 Ne Miami Gardens Dr, # 403, N Miami Beach, FL 33179 Phone: 305-957-1977    Fax: 305-957-8858

Sheldon E Kalmutz, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 16750 Ne 10th Ave, N Miami Beach, FL 33162 Phone: 561-487-0234

News Archive

Life Technologies announces the Ion AmpliSeq Exome Certified Service Provider program

Life Technologies Corporation today announces the Ion AmpliSeq™ Exome Certified Service Provider program, a global organization of some of the world's top service providers that will sequence and analyze human exomes in as little as two days.

Wyeth receives European approval for TORISEL

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the European Commission has approved TORISEL (temsirolimus) for the first-line treatment of patients with advanced renal cell carcinoma (RCC) who have at least three of six prognostic risk factors. TORISEL is the only approved cancer therapy that specifically inhibits the mTOR (mammalian target of rapamycin) kinase, an important regulator of cell proliferation, cell growth and cell survival.

Hospitalizations for injection drug use-related infective endocarditis increasing among young Americans

Hospitalizations for infective endocarditis, a heart valve infection often attributed to injection drug use, have increased significantly among young adult Americans-particularly in whites and females-according to a new study by researchers from Tufts Medical Center and Tufts University School of Medicine.

Wisepower acquires Unidym

Arrowhead Research Corporation today announced that its Unidym, Inc. subsidiary has been acquired by Wisepower Co., Ltd., a publicly-traded, Seoul, Korea-based electronics company. Upfront consideration to Unidym shareholders consists of Wisepower stock and convertible bonds valued at US $5,000,000 with certain restrictions as to timing of stock sales.

EGFR inhibitors show promise for obesity

Once-promising drugs that were abandoned in the fight against breast cancer still could be effective in obese patients, new research suggests.

Read more Medical News

› Verified 1 days ago